Impact of exacerbation history on dupilumab efficacy in children with asthma in the VOYAGE study

Theresa Guilbert; Alberto Tolcachier; Alessandro Fiocchi; Constance Katelaris; Wanda Phipatanakul; Philippe Begin; Arman Altincatal; Rebecca Gall; Olivier Ledanois; Amr Radwan; Juby Jacob-Nara; Yamo Deniz; Paul Rowe

doi:10.1016/j.jaci.2022.12.064

Impact of exacerbation history on dupilumab efficacy in children with asthma in the VOYAGE study

Theresa Guilbert, Alberto Tolcachier, Alessandro Fiocchi, Constance Katelaris, Wanda Phipatanakul, Philippe Begin, Arman Altincatal, Rebecca Gall, Olivier Ledanois, Amr Radwan, Juby Jacob-Nara, Yamo Deniz, Paul Rowe

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	AB19-AB19
Number of pages	1
Journal	Journal of Allergy and Clinical Immunology
Volume	151
Issue number	2
DOIs	https://doi.org/10.1016/j.jaci.2022.12.064
Publication status	Published - 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jaci.2022.12.064

Cite this

Guilbert, T., Tolcachier, A., Fiocchi, A., Katelaris, C., Phipatanakul, W., Begin, P., Altincatal, A., Gall, R., Ledanois, O., Radwan, A., Jacob-Nara, J., Deniz, Y., & Rowe, P. (2023). Impact of exacerbation history on dupilumab efficacy in children with asthma in the VOYAGE study. Journal of Allergy and Clinical Immunology, 151(2), AB19-AB19. https://doi.org/10.1016/j.jaci.2022.12.064

@article{b9485e2811b14d38a8eea8be7feea009,

title = "Impact of exacerbation history on dupilumab efficacy in children with asthma in the VOYAGE study",

author = "Theresa Guilbert and Alberto Tolcachier and Alessandro Fiocchi and Constance Katelaris and Wanda Phipatanakul and Philippe Begin and Arman Altincatal and Rebecca Gall and Olivier Ledanois and Amr Radwan and Juby Jacob-Nara and Yamo Deniz and Paul Rowe",

year = "2023",

doi = "10.1016/j.jaci.2022.12.064",

language = "English",

volume = "151",

pages = "AB19--AB19",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Elsevier",

number = "2",

}

Guilbert, T, Tolcachier, A, Fiocchi, A, Katelaris, C, Phipatanakul, W, Begin, P, Altincatal, A, Gall, R, Ledanois, O, Radwan, A, Jacob-Nara, J, Deniz, Y & Rowe, P 2023, 'Impact of exacerbation history on dupilumab efficacy in children with asthma in the VOYAGE study', Journal of Allergy and Clinical Immunology, vol. 151, no. 2, pp. AB19-AB19. https://doi.org/10.1016/j.jaci.2022.12.064

TY - JOUR

T1 - Impact of exacerbation history on dupilumab efficacy in children with asthma in the VOYAGE study

AU - Guilbert, Theresa

AU - Tolcachier, Alberto

AU - Fiocchi, Alessandro

AU - Katelaris, Constance

AU - Phipatanakul, Wanda

AU - Begin, Philippe

AU - Altincatal, Arman

AU - Gall, Rebecca

AU - Ledanois, Olivier

AU - Radwan, Amr

AU - Jacob-Nara, Juby

AU - Deniz, Yamo

AU - Rowe, Paul

PY - 2023

Y1 - 2023

UR - https://hdl.handle.net/1959.7/uws:72916

U2 - 10.1016/j.jaci.2022.12.064

DO - 10.1016/j.jaci.2022.12.064

M3 - Article

SN - 0091-6749

VL - 151

SP - AB19-AB19

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

IS - 2

ER -

Impact of exacerbation history on dupilumab efficacy in children with asthma in the VOYAGE study

UN SDGs

Access to Document

Other files and links

Cite this